Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Inovio Soars as Reddit Crowd Takes Notice, BlackRock Boosts Stake
By Rob Lenihan
Feb 2, 2021 9:06 AM EST
PRESS RELEASES
BioCryst To Present Data At 2021 American Academy Of Allergy, Asthma & Immunology Annual Meeting
By GlobeNewswire
Feb 9, 2021 7:15 AM EST
PRESS RELEASES
BioCryst Announces FDA Approval Of Supplemental New Drug Application For RAPIVAB® Expanding Patient Population To Include Children Six Months And Older
By GlobeNewswire
Feb 3, 2021 7:00 AM EST
INVESTING
Inovio Soars as Reddit Crowd Takes Notice, BlackRock Boosts Stake
By Rob Lenihan
Feb 2, 2021 9:06 AM EST
PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Feb 2, 2021 7:00 AM EST
JIM CRAMER
Accentuate the Positive: Cramer's 'Mad Money' Recap (Monday 1/11/21)
By Scott Rutt
Jan 11, 2021 8:27 PM EST
PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Jan 7, 2021 7:00 AM EST
PRESS RELEASES
BioCryst To Present At 39th Annual J.P. Morgan Healthcare Conference
By GlobeNewswire
Jan 6, 2021 7:00 AM EST
PRESS RELEASES
BioCryst Provides Update On Galidesivir Program
By GlobeNewswire
Dec 22, 2020 7:00 AM EST
PRESS RELEASES
BioCryst To Present At JMP Securities Hematology Summit
By GlobeNewswire
Dec 11, 2020 7:00 AM EST
PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Dec 1, 2020 4:15 PM EST
PRESS RELEASES
BioCryst To Present At Upcoming Virtual Investment Conferences
By GlobeNewswire
Nov 20, 2020 7:00 AM EST
PRESS RELEASES
BioCryst Presents Data Showing Sustained Attack Rate Reductions, Improved Patient Satisfaction And Quality Of Life For HAE Patients Taking Berotralstat In APeX-2 Trial
By GlobeNewswire
Nov 13, 2020 7:02 AM EST
PRESS RELEASES
BioCryst Presents New Data Highlighting Burden Of Therapy With Current Injectable Prophylaxis Medication For HAE
By GlobeNewswire
Nov 13, 2020 7:00 AM EST
PRESS RELEASES
BioCryst To Present Data At The 2020 ASH Annual Meeting
By GlobeNewswire
Nov 12, 2020 7:00 AM EST
PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Nov 2, 2020 4:15 PM EST
PRESS RELEASES
MHRA Grants HAE Patients Early Access To BioCryst's Berotralstat In United Kingdom
By GlobeNewswire
Oct 30, 2020 8:15 AM EDT
PRESS RELEASES
Biocryst To Present Abstracts At Annual Scientific Meeting Of American College Of Allergy, Asthma & Immunology
By GlobeNewswire
Oct 28, 2020 7:00 AM EDT
PRESS RELEASES
BioCryst To Report Third Quarter 2020 Financial Results On November 5
By GlobeNewswire
Oct 22, 2020 4:15 PM EDT
PRESS RELEASES
Journal Of Allergy And Clinical Immunology Publishes Results From BioCryst's APeX-2 Pivotal Trial Of Oral, Once-Daily Berotralstat For The Prevention Of HAE Attacks
By GlobeNewswire
Oct 22, 2020 7:00 AM EDT
PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Oct 5, 2020 4:15 PM EDT
PRESS RELEASES
BioCryst's Oral Factor D Inhibitor, BCX9930, Shows Clinical Benefit As Monotherapy Through 400 Mg Bid In Treatment-naïve PNH Patients
By GlobeNewswire
Sep 30, 2020 7:00 AM EDT
PRESS RELEASES
BioCryst To Present At 22nd Annual H.C. Wainwright Global Investment Conference
By GlobeNewswire
Sep 8, 2020 7:00 AM EDT
PRESS RELEASES
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Sep 3, 2020 4:15 PM EDT
PRESS RELEASES
U.S. Government Exercises Option To Purchase Additional RAPIVAB® From BioCryst For Delivery To Strategic National Stockpile
By GlobeNewswire
Sep 3, 2020 7:00 AM EDT
